Pumps, sensors and closed-loop systems
Last reviewed November 17, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
Technology has changed type 1 diabetes more in the last ten years than in the previous forty. Sensors replaced finger pricks, and systems that adjust insulin automatically are now standard care in many places.
They reduce the burden substantially. They do not remove it, and a system described as an artificial pancreas still needs the person to count carbohydrate and change sites.
Related pages: Type 1 diabetes
The bottom line
- Continuous glucose monitoring improves control and reduces severe hypoglycemia.
- Time in range, 70 to 180 mg/dL, is the standard metric, with above 70 percent a common target.
- Automated insulin delivery systems adjust basal insulin using sensor readings.
- These systems are hybrid: meals still need user-entered boluses.
- Alarm fatigue and device burden are genuine problems.
- How much closed-loop systems improve long-term complications.
- When fully automated systems will remove meal announcements.
- How to close the equity gap in access to technology.
The story, step by step
What the evidence labels mean
What continuous monitoring does
What happens
A reading every few minutes.
What the research shows
- A small sensor worn on the arm or abdomen measures glucose in the fluid under the skin, typically for 10 to 15 days.
- Readings go to a phone or receiver with trend arrows showing direction and speed of change, which is information a finger prick cannot give.
- Alarms warn of lows and highs, including overnight, which is where severe hypoglycemia is most dangerous.
- Sensor glucose lags blood glucose by several minutes, so during a rapid fall the blood value is lower than the screen shows. This matters when treating a low.
- Most current systems need no finger-prick calibration, though a confirmatory finger stick is advised when symptoms and readings disagree.
- Compression lows, false low readings caused by lying on the sensor, are a common and harmless artefact worth recognising.
Why it matters
Trend arrows change decisions more than the number does: 90 and falling fast is an entirely different situation from 90 and steady.
What's still uncertain
- How much CGM reduces long-term complications.
- How to improve sensor accuracy during rapid change.
Read more
- NIDDK: Managing diabetesGovernment
- MedlinePlus: Blood glucoseGovernment
- American Diabetes Association: standards of care resourcesNonprofit
Next: Time in range
The metric that replaced A1C alone
What happens
A picture of the day.
What the research shows
- Time in range is the proportion of readings between 70 and 180 mg/dL. A common adult target is above 70 percent.
- Time below range, under 70 mg/dL, is targeted at under 4 percent, with under 1 percent below 54.
- Time above range and glucose variability are reported alongside.
- Roughly, each 10 percent increase in time in range corresponds to about a 0.5 percent fall in A1C.
- Unlike A1C, it shows when problems happen, which is what actually guides a change in insulin.
- It also exposes something A1C hides entirely: a respectable A1C produced by averaging frequent highs and dangerous lows.
Why it matters
Time in range made it possible to tell the difference between good control and an average that happens to look good.
What's still uncertain
- Whether time-in-range targets predict complications as well as A1C.
- The right targets for children and older adults.
Read more
- American Diabetes Association: standards of care resourcesNonprofit
- NIDDK: Managing diabetesGovernment
- MedlinePlus: Blood glucoseGovernment
Next: Closed loop
Automated insulin delivery
What happens
The pump reads the sensor.
What the research shows
- A hybrid closed-loop system links a pump and a sensor through an algorithm that adjusts basal insulin every few minutes.
- It increases insulin when glucose is rising and reduces or suspends it when falling, which prevents many lows, particularly overnight.
- Trials and real-world data show improved time in range and reduced hypoglycemia across age groups, including young children and older adults.
- Hybrid means the user still announces meals and enters carbohydrate. The system handles background insulin and corrections between meals.
- Exercise usually needs a temporary target change set in advance, because the algorithm reacts to a fall rather than anticipating it.
- Fully automated systems that require no meal entry are in development and are not yet standard.
Why it matters
The overnight benefit is the one people describe as life-changing, because it is the first time in decades of diabetes that sleep has not required vigilance.
What's still uncertain
- How much these systems reduce long-term complications.
- When meal announcement will become unnecessary.
Read more
- American Diabetes Association: standards of care resourcesNonprofit
- NIDDK: Managing diabetesGovernment
- FDA: drug and device informationGovernment
Next: The downsides
Devices on a body
What happens
Rarely discussed in the brochure.
What the research shows
- Alarm fatigue is real. Frequent alerts, particularly at night, lead people to silence or abandon systems.
- Adhesive reactions, skin irritation and scarring at sites are common, and site rotation matters for sensors as well as cannulas.
- Devices are visible, and for adolescents in particular that visibility affects whether they are worn.
- Failures happen: sensors fall off, cannulas kink, phones update at the wrong moment. Backup injectable insulin and a meter must always be available.
- Cost and insurance coverage remain the largest barrier, and access is markedly unequal by income and ethnicity even within the same health systems.
- Technology also raises expectations, and not meeting a time-in-range target can become another source of guilt.
Why it matters
The most common reason technology does not help is that it stops being worn, and the reasons for that are practical and emotional rather than technical.
What's still uncertain
- How to reduce alarm fatigue without reducing safety.
- How to close the equity gap in device access.